A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”
Crossref DOI link: https://doi.org/10.1007/s12325-023-02495-0
Published Online: 2023-04-01
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ismaila, Afisi S.
Haeussler, Katrin
Malmenäs, Mia
Sharma, Raj
Compton, Chris
Vogelmeier, Claus F.
Han, MeiLan K.
Halpin, David M. G.
Text and Data Mining valid from 2023-04-01
Version of Record valid from 2023-04-01
Article History
Received: 31 January 2023
Accepted: 9 March 2023
First Online: 1 April 2023